Perspective Therapeutics, Inc. — Director's Dealing 2018

Jun 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-06-13

Reporting Person: Krachon Michael (VP of Sales & Marketing)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-13	Stock Options (right to buy)	$0.46	A	150000	Acquired	2028-06-13	Common Stock (150000)	Direct

Footnotes

F1: 25% vested as of 6/13/2018, and the remaining 75% will vest over the next three (3) years, commencing on 6/13/2019, until fully vested.